Search

Search Constraints

You searched for: Author/Creator Ebert, Matthias

Search Results

4. Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy. Issue 1 (December 2018)

5. Correlating laser‐generated melts with impact‐generated melts: An integrated thermodynamic‐petrologic approach. Issue 20 (28th October 2016)

6. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022)

7. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study. (January 2022)

8. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (February 2022)

9. Experimental impact cratering: A summary of the major results of the MEMIN research unit. (16th February 2018)

10. FOXA2 prevents hyperbilirubinaemia in acute liver failure by maintaining apical MRP2 expression. Issue 3 (20th April 2022)